Immobilised Burkholderia cepacia lipase in dry organic solvents and ionic liquids: A comparison
被引:42
作者:
Hara, Piia
论文数: 0引用数: 0
h-index: 0
机构:
Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synth Drug Chem, FIN-20520 Turku, Finland
Univ Turku, Dept Chem, FIN-20520 Turku, FinlandUniv Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synth Drug Chem, FIN-20520 Turku, Finland
Hara, Piia
[1
,2
]
Hanefeld, Ulf
论文数: 0引用数: 0
h-index: 0
机构:
Tech Univ Delft, Afdeling Biotechnol, NL-2628 BL Delft, NetherlandsUniv Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synth Drug Chem, FIN-20520 Turku, Finland
Hanefeld, Ulf
[3
]
Kanerv, Liisa T.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synth Drug Chem, FIN-20520 Turku, Finland
Univ Turku, Dept Chem, FIN-20520 Turku, FinlandUniv Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synth Drug Chem, FIN-20520 Turku, Finland
Kanerv, Liisa T.
[1
,2
]
机构:
[1] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synth Drug Chem, FIN-20520 Turku, Finland
[2] Univ Turku, Dept Chem, FIN-20520 Turku, Finland
Lipase PS from Burkholderia cepacia in its free, commercial form (BCL-PS), immobilised in a sol-gel (BCLxero) and as a CLEA (BCL-CLEA) was tested in dry organic solvents, ionic liquids and their mixtures. Utilising the acylations of secondary alcohols 1-3 the influence of the enzyme preparation on its activity and enantioselectivity was studied. BCL-CLEA displays higher activity (initial rates) than BCLxero for all substrates in the ILs but loses its activity rapidly. Thus, BCLxero is suitable for kinetic resolution in ILs and in their mixtures with organic solvents. It is not possible to label one IL better than the other without taking the nature of the substrate into account. In neat solvents, the nature of the solvent affects enantioselectivity (E) only when furyl-substituted alcohol 2 serves as a substrate while variation in E is more evident for reactions in solvent mixtures.
机构:
Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synthet Drug Chem, FIN-20520 Turku, Finland
Univ Turku, Dept Chem, FIN-20520 Turku, FinlandUniv Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synthet Drug Chem, FIN-20520 Turku, Finland
Hara, Piia
论文数: 引用数:
h-index:
机构:
Hanefeld, Ulf
Kanerva, Liisa T.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synthet Drug Chem, FIN-20520 Turku, Finland
Univ Turku, Dept Chem, FIN-20520 Turku, FinlandUniv Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synthet Drug Chem, FIN-20520 Turku, Finland
机构:
Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synthet Drug Chem, FIN-20520 Turku, Finland
Univ Turku, Dept Chem, FIN-20520 Turku, FinlandUniv Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synthet Drug Chem, FIN-20520 Turku, Finland
Hara, Piia
论文数: 引用数:
h-index:
机构:
Hanefeld, Ulf
Kanerva, Liisa T.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synthet Drug Chem, FIN-20520 Turku, Finland
Univ Turku, Dept Chem, FIN-20520 Turku, FinlandUniv Turku, Dept Pharmacol Drug Dev & Therapeut, Lab Synthet Drug Chem, FIN-20520 Turku, Finland